Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Oct;66(10):903-9.
doi: 10.1136/thx.2010.146118. Epub 2010 Dec 16.

Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies

Collaborators, Affiliations
Randomized Controlled Trial

Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies

P J Castaldi et al. Thorax. 2011 Oct.

Abstract

Background: The identification of gene-by-environment interactions is important for understanding the genetic basis of chronic obstructive pulmonary disease (COPD). Many COPD genetic association analyses assume a linear relationship between pack-years of smoking exposure and forced expiratory volume in 1 s (FEV(1)); however, this assumption has not been evaluated empirically in cohorts with a wide spectrum of COPD severity.

Methods: The relationship between FEV(1) and pack-years of smoking exposure was examined in four large cohorts assembled for the purpose of identifying genetic associations with COPD. Using data from the Alpha-1 Antitrypsin Genetic Modifiers Study, the accuracy and power of two different approaches to model smoking were compared by performing a simulation study of a genetic variant with a range of gene-by-smoking interaction effects.

Results: Non-linear relationships between smoking and FEV(1) were identified in the four cohorts. It was found that, in most situations where the relationship between pack-years and FEV(1) is non-linear, a piecewise linear approach to model smoking and gene-by-smoking interactions is preferable to the commonly used total pack-years approach. The piecewise linear approach was applied to a genetic association analysis of the PI*Z allele in the Norway Case-Control cohort and a potential PI*Z-by-smoking interaction was identified (p=0.03 for FEV(1) analysis, p=0.01 for COPD susceptibility analysis).

Conclusion: In study samples of subjects with a wide range of COPD severity, a non-linear relationship between pack-years of smoking and FEV(1) is likely. In this setting, approaches that account for this non-linearity can be more powerful and less biased than the more common approach of using total pack-years to model the smoking effect.

PubMed Disclaimer

Conflict of interest statement

COMPETING INTERESTS:

PDP served on the Advisory Board for Talecris Biotherapeutics and received grant support from GSK, Merck, $100,001 or more, the NIH $50,001–$100,000, CIHR (Canada), and AllerGenNCE $100,001 or more.

Figures

Figure 1
Figure 1
Figures 1-D. FEV1, % predicted by pack-years scatterplot in 4 large cohorts (Panel A, Alpha-1 Antitrypsin Genetic Modifiers Study; Panel B, Boston Early-Onset COPD Study; Panel C, Norway Case-Control Study; Panel D, International COPD Genetics Network) with smoothing curve. Flattening of curve occurs at FEV1 levels between 30 and 50% of predicted.
Figure 1
Figure 1
Figures 1-D. FEV1, % predicted by pack-years scatterplot in 4 large cohorts (Panel A, Alpha-1 Antitrypsin Genetic Modifiers Study; Panel B, Boston Early-Onset COPD Study; Panel C, Norway Case-Control Study; Panel D, International COPD Genetics Network) with smoothing curve. Flattening of curve occurs at FEV1 levels between 30 and 50% of predicted.
Figure 1
Figure 1
Figures 1-D. FEV1, % predicted by pack-years scatterplot in 4 large cohorts (Panel A, Alpha-1 Antitrypsin Genetic Modifiers Study; Panel B, Boston Early-Onset COPD Study; Panel C, Norway Case-Control Study; Panel D, International COPD Genetics Network) with smoothing curve. Flattening of curve occurs at FEV1 levels between 30 and 50% of predicted.
Figure 1
Figure 1
Figures 1-D. FEV1, % predicted by pack-years scatterplot in 4 large cohorts (Panel A, Alpha-1 Antitrypsin Genetic Modifiers Study; Panel B, Boston Early-Onset COPD Study; Panel C, Norway Case-Control Study; Panel D, International COPD Genetics Network) with smoothing curve. Flattening of curve occurs at FEV1 levels between 30 and 50% of predicted.
Figure 2
Figure 2
Observed power to detect gene-by-smoking interactions for the pack-years versus piecewise linear approach to model smoking. Simulation study based on data from the Genetic Modifiers of Alpha-1 Antitrypsin Disease Study. Simulation parameters are as follows: minor allele frequency = 25%, genetic main effect = −1 unit from observed FEV1 percent predicted per copy of minor allele, gene-by-smoking effect varies as shown. For this power analysis, the threshold for detecting an effect was set at alpha <0.05 for the null hypothesis that the gene-by-smoking effect is equal to zero. For gene-by-smoking effects the piecewise linear model is more powerful. At low values of the gene-by-smoking interaction, the total pack-years approach appears more powerful due to upwardly biased estimates of the gene-by-smoking interaction (values shown in Table 2).

Comment in

  • A spline for the time.
    Schwartz J. Schwartz J. Thorax. 2011 Oct;66(10):841-2. doi: 10.1136/thx.2010.154195. Epub 2011 May 26. Thorax. 2011. PMID: 21617170 No abstract available.

References

    1. Rachet B, Siemiatycki J, Abrahamowicz M, Leffondre K. A flexible modeling approach to estimating the component effects of smoking behavior on lung cancer. Journal of Clinical Epidemiology. 2004;57(10):1076–1085. - PubMed
    1. Hoffmann K, Bergmann MM. Re: “Modeling smoking history: a comparison of different approaches”. American Journal of Epidemiology. 2003;158(4):393–394. - PubMed
    1. Dockery DW, Speizer FE, Ferris BG, Jr, Ware JH, Louis TA, Spiro A., III Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. American Review of Respiratory Disease. 1988;137(2):286–292. - PubMed
    1. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. American Review of Respiratory Disease. 1977;115(2):195–205. - PubMed
    1. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG., Jr Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. American Review of Respiratory Disease. 1992;146(5 Pt 1):1345–1348. - PubMed

Publication types

MeSH terms